Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - Concepedia

Concepedia

Publication | Open Access

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

DOI Full Paper Access

30

Citations

25

References

2023

Year

Marissa Meegdes, Sandra M. E. Geurts, Frans Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. Pepels, Linda M. H. van de Winkel, Natascha A. J. B. Peters, Jolien Tol,

The Lancet Regional Health - Europe

Abstract

The SONABRE Registry is supported by the Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); Novartis BV; Roche; Pfizer; and Eli Lilly & Co. Funding sources had no role in the writing of the manuscript.

References

	Year	Citations

Page 1